Author

Albert D. Windhorst

Amsterdam NeuroscienceORCID 0000-0002-1250-7656Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Ádám DénesiD· 1 shared Arno de WildeiD· 1 shared Barbara A. ZarzyckaiD· 1 shared Bart N.M. van BerckeliD· 1 shared Bastian ZinnhardtiD· 1 shared Berend van der WildtiD· 1 shared Charles S. ElmoreiD· 1 shared Charlotte Elisabeth TeunisseniD· 1 shared

Activity by Year

2019-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Ádám DénesORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Characterization of AZ12464237 as a high affinity, non-nucleotide antagonist radioligand for the P2Y12 receptor

E. Johanna L. Stéen, Efthalia-Natalia Tousiaki, Lee P. Kingston, Berend van der Wildt, Nikolett Lénárt, Wissam Beaino, Mariska Verlaan, Barbara A. Zarzycka, Bastian Zinnhardt, Ádám Dénes, Luca B. Gobbi, Iwan J. P. de Esch, Charles S. Elmore, Albert D. Windhorst, Michael Honer, Rob Leurs

This paper characterizes [3H]AZ12464237 as a high-affinity radioligand for the P2Y12 receptor, showing selectivity and utility in in vitro studies.

Biochemical Pharmacology · Apr 3, 2025Peer-reviewedPharmacology & Toxicology

PET and CSF amyloid-β status are differently predicted by patient features: Information from discordant cases

Juhan Reimand, Arno de Wilde, Charlotte Elisabeth Teunissen, Marissa Deborah Zwan, Albert D. Windhorst, Ronald Boellaard, Frederik Barkhof, Wiesje M. van der Flier, Philip Scheltens, Bart N.M. van Berckel, Rik Ossenkoppele, Femke H. Bouwman

The paper finds that patient features differentially predict amyloid-β status based on PET or CSF, with variations by disease stage, suggesting PET and CSF discordance provides unique information.

Alzheimer s Research & Therapy · Dec 1, 2019Peer-reviewedNeuroscience